Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Iovance Biotherapeutics, Inc. - Common Stock
(NQ:
IOVA
)
2.690
+0.150 (+5.90%)
Streaming Delayed Price
Updated: 3:29 PM EDT, Aug 22, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Why Iovance Biotherapeutics Stock Was Climbing Today
August 19, 2025
One and a half years after getting the nod from the U.S. Food and Drug Administration, its Amtagvi moves forward in a neighboring country.
Via
The Motley Fool
Iovance Stock Rises 4% On Health Canada Approval For Cancer Immunotherapy: Retail Thinks ‘Patience Will Pay Off’
August 19, 2025
Via
Stocktwits
Intel, Plymouth Industrial REIT, Premier And Other Big Stocks Moving Higher On Tuesday
August 19, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 19, 2025
Via
Benzinga
Earnings Scheduled For August 7, 2025
August 07, 2025
Via
Benzinga
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
August 19, 2025
Via
Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday?
August 18, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
August 18, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
3 Stocks That Could Turn $1,000 Into $5,000 by 2030
August 09, 2025
All three of these companies are entering a period of what could produce unparalleled top- and bottom-line growth.
Via
The Motley Fool
Why Iovance Biotherapeutics Stock Plummeted Today
August 08, 2025
The company's top line nearly doubled.
Via
The Motley Fool
What 7 Analyst Ratings Have To Say About Iovance Biotherapeutics
August 08, 2025
Via
Benzinga
Pinterest Posts Downbeat Q2 Earnings, Joins Twilio, Trade Desk And Other Big Stocks Moving Lower In Friday Pre-Market Session
August 08, 2025
Via
Benzinga
Which stocks are moving before the opening bell on Friday?
August 08, 2025
Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 08, 2025
Via
Benzinga
Iovance Biotherapeutics Declines 29% In Premarket Trading: Here's What's Happening
August 08, 2025
Iovance stock fell over 29% pre-market after Q2 results, despite reporting a strong revenue jump led by Amtagvi sales.
Via
Benzinga
Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
August 08, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 07, 2025
Via
Benzinga
Curious about the stocks that are showing activity after the closing bell on Thursday?
August 07, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
Iovance (IOVA) Q2 Revenue Jumps 93%
August 07, 2025
Via
The Motley Fool
Topics
Intellectual Property
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025
August 07, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Is Iovance Biotherapeutics Stock Due for a Big Rally?
July 30, 2025
The biotech stock has been picking up steam of late -- but will it last?
Via
The Motley Fool
This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy?
July 29, 2025
Even the average price estimate for this stock suggests it can soar, but not everyone's convinced.
Via
The Motley Fool
Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025
July 24, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
July 24, 2025
Via
Benzinga
Here are the top movers in Wednesday's session.
July 23, 2025
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 23, 2025
Via
Benzinga
GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday
July 23, 2025
Via
Benzinga
These stocks are gapping in today's session
July 23, 2025
The market is filled with gapping stocks in Wednesday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
Analyst Expectations For Iovance Biotherapeutics's Future
July 23, 2025
Via
Benzinga
Health In Tech (NASDAQ: HIT) Posts Blowout Q2, Stock Responds – HIT, SNYR, PNPN.V/PNPNF in Breakout Zone; See More to Watch Inside
July 22, 2025
Via
AB Newswire
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.